Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach.

Autor: Caminati M; Department of Medicine, University of Verona, Verona, Italy.; Allergy Unit and Asthma Center, Verona Integrated University Hospital, Verona, Italy., Carpagnano LF; University of Verona, Verona Italy., Alberti C; Pharmacy Unit, Verona Integrated University Hospital, Verona, Italy., Amaddeo F; Unit of Psychosomatics and Medical Psychology, Verona Integrated University Hospital, and Department of Neurosciences, Biomedicine and Movement, University of Verona, Italy., Bixio R; Rheumatology Unit, Verona Integrated University Hospital, Verona, Italy., Caldart F; Gastroenterology and Digestive Endoscopy Unit, The Pancreas Institute, Verona Integrated University Hospital, Verona, Italy., De Franceschi L; Department of Medicine, University of Verona, Verona, Italy.; Unit of Internal Medicine B, Verona Integrated University Hospital, Verona Italy., Del Giglio M; Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy., Festi G; Pulmonology Unit, Verona Integrated University Hospital, Verona Italy., Friso S; Department of Medicine, University of Verona, Verona, Italy.; Unit of Internal Medicine B, Verona Integrated University Hospital, Verona Italy., Frulloni L; Department of Medicine, University of Verona, Verona, Italy.; Gastroenterology and Digestive Endoscopy Unit, The Pancreas Institute, Verona Integrated University Hospital, Verona, Italy., Gisondi P; Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy., Krampera M; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona, Verona, Italy., Lippi G; Section of Clinical Biochemistry and School of Medicine, University of Verona, Verona, Italy., Micheletto C; Pulmonology Unit, Verona Integrated University Hospital, Verona Italy., Piacentini G; Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Pediatric Clinic, University of Verona, Verona, Italy., Pinter P; Unit of Otolaryngology, Head and Neck Department, University of Verona, Verona, Italy., Rossini M; Department of Medicine, University of Verona, Verona, Italy.; Rheumatology Unit, Verona Integrated University Hospital, Verona, Italy., Schiappoli M; Allergy Unit and Asthma Center, Verona Integrated University Hospital, Verona, Italy., Tecchio C; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona, Verona, Italy., Tenero L; Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Pediatric Clinic, University of Verona, Verona, Italy., Tinazzi E; Unit of Internal Medicine B, Verona Integrated University Hospital, Verona Italy., Senna G; Department of Medicine, University of Verona, Verona, Italy.; Allergy Unit and Asthma Center, Verona Integrated University Hospital, Verona, Italy., Carlucci M; Health Directorate, Verona Integrated University Hospital, Verona, Italy.

Publikováno v: The World Allergy Organization journal [World Allergy Organ J] 2024 Jul 25; Vol. 17 (8), pp. 100928. Date of Electronic Publication: 2024 Jul 25 (Print Publication: 2024).

Relevance of TH2 Markers in the Assessment and Therapeutic Management of Severe Allergic Asthma: A Real-Life Perspective

Autor: Caminati, M, Vianello, A, Chieco Bianchi, F, Festi, G, Guarnieri, G, Marchi, M R, Micheletto, C, Olivieri, M, Tognella, S, Guerriero, M, Senna, G, NEONET Study Group

Publikováno v: Journal of investigational allergologyclinical immunology. 30(1)

BACKGROUND Although blood eosinophils are currently recognized as the main clinical marker of TH2-type inflammation, their relevance in identifying asthma severity remains a matter of debate. METHODS Our retrospective real-life study on severe asthma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f35c230ecabfc4f5ca35bcb77e70170
https://pubmed.ncbi.nlm.nih.gov/30676321

Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?"

Autor: Caminati M; Department of Medicine, University of Verona and Verona University Hospital, Verona, Italy. Electronic address: marco.caminati@univr.it., Crisafulli E; Department of Medicine, Respiratory Medicine Unit and Section of Internal Medicine, University of Verona and Verona University Hospital, Verona, Italy., Lunardi C; Department of Medicine, University of Verona and Verona University Hospital, Verona, Italy., Micheletto C; Cardio-Thoracic Department, Respiratory Unit, Integrated University Hospital, Verona, Italy., Festi G; Cardio-Thoracic Department, Respiratory Unit, Integrated University Hospital, Verona, Italy., Maule M; Department of Medicine, University of Verona, Specialization Course in Allergy and Clinical Immunology, Verona, Italy., Giollo A; Division of Rheumatology, Department of Medicine, University of Verona and Verona University Hospital, Verona, Italy., Orsolini G; Division of Rheumatology, Department of Medicine, University of Verona and Verona University Hospital, Verona, Italy., Senna G; Department of Medicine, University of Verona and Verona University Hospital, Verona, Italy; Allergy Unit and Asthma Center, Verona University Hospital, Verona, Italy.

Publikováno v: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2021 Jul; Vol. 9 (7), pp. 2943-2944.

Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response.

Autor: Caminati M; Asthma Center and Allergy Unit, Verona University Hospital, Verona, Italy.; Department of Medicine, University of Verona, Verona, Italy., Cegolon L; Local Health Unit N. 2 'Marca Trevigiana', Public Health Department, Treviso, Veneto Region, Italy., Vianello A; Respiratory Pathophysiology Division, University-City Hospital of Padua, Padua, Italy., Chieco Bianchi F; Respiratory Pathophysiology Division, University-City Hospital of Padua, Padua, Italy., Festi G; Pulmonary Unit, Verona University Hospital, Verona, Italy., Marchi MR; Respiratory Pathophysiology Division, University-City Hospital of Padua, Padua, Italy., Micheletto C; Pulmonary Unit, Verona University Hospital, Verona, Italy., Mazza F; Pulmonary Unit, Presidio Ospedaliero di Pordenone, Pordenone, Italy., Tognella S; Respiratory Unit, Orlandi General Hospital, Verona, Italy., Senna G; Asthma Center and Allergy Unit, Verona University Hospital, Verona, Italy.

Publikováno v: Expert review of respiratory medicine [Expert Rev Respir Med] 2019 Dec; Vol. 13 (12), pp. 1205-1212. Date of Electronic Publication: 2019 Oct 16.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.